The Value of Advanced MR Imaging in Gynecological Tumors and Benign Uterine Fibroids

Inclusion Criteria: * Participants with suspected or histologically confirmed diagnosis of primary or recurrent gynecological cancer including uterine endometrial, cervical, vaginal, vulvar, ovarian, and smooth-muscle tumors undergoing routine clinical standard of care pelvic MRI * Control subjects with benign fibroids undergoing routine clinical standard of care pelvic MRI * Age ≥ 18 years * ECOG performance status of ≤ 2, based on treating physician's discretion (Appendix A) * Ability to understand and the willingness to sign a written informed consent document Exclusion Criteria: * Contraindication to MRI identified by the MR procedure screening form, such as a pacemaker, aneurysm clip, inner ear implant, neurostimulator, or other MR non-compatible device or implant * Uncontrolled intercurrent illness including, but not limited to ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements * Adults unable to consent * Non-english speaking subjects * Pregnant women * Prisoners